Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Opiant Pharmaceuticals Inc (NQ: OPNT )

12.66 USD -0.37 (-2.84%)
Official Closing Price Updated: 4:00 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 30,000
Open 12.89
Bid (Size) 12.25 (1)
Ask (Size) 14.00 (1)
Prev. Close 13.03
Today's Range 12.35 - 13.21
52wk Range 6.788 - 14.98
Shares Outstanding 2,697,174
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Opiant Pharmaceuticals to Report Fourth Quarter 2020 Financial Results and Host Conference Call and Webcast on March 4, 2021
From GlobeNewswire News Releases
Opiant Pharmaceuticals Announces First Patient Dosed in Confirmatory Pharmacokinetic Study Assessing OPNT003, Nasal Nalmefene, for the Treatment of Opioid Overdose
From GlobeNewswire News Releases

Performance

YTD
+54.39%
+54.39%
1 Month
+17.33%
+17.33%
3 Month
+49.47%
+49.47%
6 Month
+44.85%
+44.85%
1 Year
+7.74%
+7.74%

More News

Read More
Opiant Pharmaceuticals Announces Additional $3.5 million Funding Under BARDA Contract for OPNT003 Nasal Nalmefene Development Program
From GlobeNewswire News Releases
Opiant Pharmaceuticals Secures $50 Million in Convertible Debt Financing
From GlobeNewswire News Releases
Opiant Pharmaceuticals Announces Appointment of Biopharmaceutical Leader Craig A. Collard as Chairman to its Board of Directors
From GlobeNewswire News Releases
Opiant Pharmaceuticals Announces Third Quarter 2020 Financial Results and Corporate Update
From GlobeNewswire News Releases
Opiant Pharma Advances OPNT003 PK Study With First Patient Dosing
Tags OPNT Benzinga General
From Benzinga
How The Pieces Add Up: IWC Headed For $140
Tags ETFs
From ETF Channel
12 Healthcare Stocks Moving In Monday's After-Market Session
Tags Health Care CWBR Benzinga
From Benzinga
Opiant Pharmaceuticals: Q3 Earnings Insights
Tags Benzinga OPNT Earnings
From Benzinga
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
Tags AGTC Biotech LHDX
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.